Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/3308
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.contributor.authorSistema Único de Saúde (Brasil)-
dc.contributor.authorBrasil. Ministério da Saúde-
dc.date.accessioned2021-07-13T14:30:51Z-
dc.date.available2021-07-13T14:30:51Z-
dc.date.issued2019-02-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/3308-
dc.description2 p.: tab. p&b.-
dc.language.isoPortpt_BR
dc.publisherINCApt_BR
dc.relation.ispartofseriesAno III, n. 22.-
dc.subjectHormonioterapia Adjuvantept_BR
dc.subjectNeoplasias da Mama/diagnósticopt_BR
dc.subjectNeoplasias de la Mama/diagnósticopt_BR
dc.subjectBreast Neoplasms/diagnosis-
dc.subjectNeoplasias da Mama/terapia-
dc.subjectNeoplasias de la Mama/terapia-
dc.subjectBreast Neoplasms/therapy-
dc.titleHormonioterapia adjuvante de mama de forma estendidapt_BR
dc.TypeRevistas/Boletinspt_BR
Appears in Collections:Informe SUS - ONCO 2019

Files in This Item:
File Description SizeFormat 
informe-sus-onco-fevereiro-2019.pdf488.58 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.